In this episode Ole Schmiedel discusses Mounjaro, a new weight loss drug, with a focus on its mechanism of action, practical use, side effects, nutritional considerations, and long-term safety. The conversation provides insights into how Mounjaro differs from previous GLP-1 receptor agonists, expected weight loss outcomes, and the importance of monitoring patients while on the medication.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Goodfellow Unit (University of Auckland). Innehållet i podden är skapat av The Goodfellow Unit (University of Auckland) och inte av, eller tillsammans med, Poddtoppen.